TP53 and osteosarcoma: Similarly, Sirt7 inhibition-induced drug resistance is a non-p53 mediated mechanism since the osteosarcoma SaOS-2 has p53 gene rearrangements and deletions [39] and both have decreased Sirt7 expression.